Liver Diseases  >>  Victrelis (boceprevir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Victrelis (boceprevir) / Roche, Merck (MSD)
NCT00959699 / 2008-004864-38: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Checkmark
Jun 2013 - Jun 2013: 
Completed
2b
99
NA
PegIFN-2b, SCH 054031, MK-4031, Pegylated interferon alfa-2b, Peginterferon alfa-2b, RBV, Ribavirin, Placebo to Boceprevir, Boceprevir, SCH 503034, MK-3034, Victrelis
Merck Sharp & Dohme LLC
HIV Infections, Hepatitis C, HCV Infection
05/12
10/12
NCT00160251 / 2005-001264-31: Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Completed
2
357
US
Boceprevir (BOC), SCH 503034, PegIntron (PEG), Ribavirin (RBV)
Merck Sharp & Dohme LLC
Chronic Hepatitis C
07/07
07/07
NCT00423670 / 2006-002543-92: Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

Completed
2
765
NA
boceprevir (SCH 503034), Boceprevir, Victrelis, SCH 503034, peginterferon-alfa 2b (PegIntron), ribavirin, ribavirin (low-dose)
Merck Sharp & Dohme LLC
Chronic Hepatitis C
08/08
11/08
NCT01353911 / 2011-000759-18: Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003)

Checkmark
Apr 2014 - Apr 2014: 
Checkmark IWCPHT 2013
Jul 2013 - Jul 2013: IWCPHT 2013
Checkmark APASL 2013
More
Completed
2
368
NA
Grazoprevir, Boceprevir, Victrelis, Placebo for Grazoprevir, Placebo for Boceprevir, Peg-interferon alfa-2b, PegIntron, Peg-IFN alfa-2b, Ribavirin, Rebetol
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
01/13
03/15
NCT01482403 / 2011-002714-37: A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Completed
2
58
US, Canada, Europe
Copegus, Pegasys, boceprevir, mericitabine, mericitabine placebo, boceprevir placebo
Hoffmann-La Roche
Hepatitis C, Chronic
01/14
01/14
DAHHS, NCT01912495: Dutch Acute HCV in HIV Study

Checkmark DAHHS
Jun 2014 - Jun 2014: DAHHS
Completed
2
65
Europe
Boceprevir, Victrelis
Erasmus Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Onze Lieve Vrouwe Gasthuis, UMC Utrecht, University Medical Center Groningen, Maastricht University Medical Center, Rijnstate Hospital, Slotervaart Hospital, Radboud University Medical Center
Hepatitis C, Human Immunodeficiency Virus
08/15
01/16

Download Options